16 OCTOBER NEW ZEALAND GAZETTE 3517

Name and Strength Form Name and Address of Manufacturer Proprietary Name

                                                                                                                  (if any)

Urea-¹³C 100 mg Tablet Penn Pharmaceuticals Limited, Tredegar, Gwent,
United Kingdom Urea-¹³C

Alfuzosin hydrochloride 2.5 mg Tablet, film coated Synthelabo Group, Tours, France Xatral

Alfuzosin hydrochloride 5 mg Tablet, sustained release, film
coated Synthelabo Group, Tours, France Xatral SR

Dated this 10th day of October 1997.

G. R. BOYD, Chief Advisor, Regulation and Safety, pursuant to delegation given by the Minister of Health on 20 February 1997.

go7412

Consent to the Distribution of Changed Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines which were referred to the Minister of Health under the provisions of section 24 (5) of the Act and are set out in the Schedule hereto:

Schedule

Name and Strength Form Name and Address of Manufacturer Proprietary Name

                                                                                                                  (if any)

Loratadine 10 mg Tablet, effervescent Asta Medica Arzneimittel GmbH., Wolfsberg, Austria Claratyne Effervescent

Enoxaparin sodium 100 mg/mL in 0.2 mL, 0.4 mL, Injection, pre-filled syringe Rhone-Poulenc Rorer Pharma Specialites,
0.6 mL, 0.8 mL, 1.0 mL Maisons-Alfort, France Clexane

Enoxaparin sodium 100 mg/mL in 0.6 mL, Injection, ampoules Rhone-Poulenc Rorer Pharma Specialites,
0.8 mL, 1.0 mL Maisons-Alfort, France Clexane

Tuberculin PPD 27 mg, 81 mg Injection, powder, vial; Connaught Laboratories Limited, Willowdale,
Diluent, vial Ontario, Canada ImmuCyst BCG Immunotherapeutic

Omeprazole 10 mg, 20 mg Capsules Astra Pharmaceutical Production AB., Södertälje,
Sweden Losec

Omeprazole 10 mg, 20 mg Capsules Astra Pharmaceutical Production AB., Södertälje,
Sweden Losec

Filgrastim 0.3 mg in 1 mL Injection, vial F Hoffmann-La Roche Limited, Basle, Switzerland
and Parke Davis Inc., Rochester, Michigan, United Neupogen
States of America

Filgrastim 0.3 mg in 1 mL Injection, pre-filled syringe F Hoffmann-La Roche Limited, Basle, Switzerland
and Parke Davis Inc., Rochester, Michigan, United Neupogen
States of America

Caffeine 100 mg Tablet Pan Laboratories Pty Limited, Villawood, New South
Wales, Australia No Doz

Pluronic 17R4 0.02% w/v, sodium perborate Solution, contact lens Ciba Vision-Sterile Manufacturing, Mississauga,
0.027% w/v Ontario, Canada Softwear Plus

Azithromycin dihydrate equivalent to 250 mg, Tablets, film coated Pfizer Pty Limited, West Ryde, New South Wales,
500 mg azithromycin base Australia and Pfizer Italiana SpA., Latina, Italy Zithromax

Dated this 10th day of October 1997.

G. R. BOYD, Chief Advisor, Regulation and Safety, pursuant to delegation given by the Minister of Health on 20 February 1997.

go7413

Provisional Consent to the Distribution of a New Medicine

Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicine set out in the Schedule hereto:

Schedule

Name and Strength Form Name and Address of Manufacturer Proprietary Name

                                                                                                                  (if any)

Donepezil hydrochloride 5 mg, 10 mg Tablets, film coated The Boots Company PLC., Nottingham, United
Kingdom and Pfizer SA., Amboise Cedex, France Aricept